Document XRwbv9ggwrdbkrZGJrqK9RDDR
FILE NAME: WR Grace (WRG)
DATE: August 25, 1972 DOC#: WRG269
DOCUMENT DESCRIPTION: 1972 Letter to Dr. Stokinger from JJ Marino regarding quartz and cristobalite in non-asbestos insulation
212 LR 3-3444
Q uigley company, inc.
2 3 3 E . 4 2 N D ST. N EW Y O R K . N. Y. 10017
August 25, 1972
Dr. Herbert E. Stokinger
Chief, Toxicology Branch
Div. of Laboratories &
Criteria Development
Dept, of Health, Education & Welfare 1014 Broadway
Cincinnati, Ohio 45202
.
Dear Dr. Stokinger:
Referring to your letter of July 5 and our subsequent phone conversation concerning quartz and cristobalite in our non-asbestos insulation Panelex, I have contacted our suppliers of perlite, dicalite and vermiculite. The replies were as follows:
Perlite (9% of product formulation) Our supplier "Pennsylvania Perlite Corp. Mforwarded a lab report by Walter C. McCrone Assoc. Inc. of Chicago, 111. indicating the total free silica to be less than 0. 05%.
Dicalite (2. 5% of product formulation)
Our supplier, Grefco, Inc. forwarded to us a lab report from George D.
Clayton & Assoc, and an article "Pneumoconiosis in Diatomite Mining
and Processing" by USPHS. Although the quartz content is less than 1%
the cristobalite analyzed at 61%. This cristobailite fraction calculates
out as being 1. 5% of the total product.
,
Vermiculite (26% of formulation) The attached letter from our supplier W. R. Grace indicates free silica to
be le ss than 1% (limit of their detection).
We must apologize for the inconvenience of reviewing this again. However, I feel I now know the basic requirements and hopefully in the future I can present all the data at once.
A Subtidiary of PFIZER . INC.
Dr. Herbert E. Stokinger August 25, 1972 Page 2
Based on the above we feel your previous opinion is still valid and the only modification to your July 5th. letter is to remgjjjjyi^^ concerning a 3% quartz content. If this can be done we would be very grateful.
Very truly yours,
y.yflasLvp
J. J. Marino Chief Engineer
Enclosures JJM /sb
.. % / v. n
riurx.i
III I) \